The CTLA-4 (extracellular domain) that bound CD80 was isolated from the library using Phage display techonology. After affinity maturation, CTLA-4 variants were identified having affinities for CD80 as determined by biosensor technology. It's potential to be used in diagnostic, research and therapeutic applications.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-215 | Anti-Human CD80 Recombinant Antibody (Galiximab) | WB, ELISA, FC, IP, FuncS, IF, Neut | IgG1 - lambda |
There are currently no Customer reviews or questions for SCT-L065. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.